ResultsIQ

ResultsIQ › Latest results › Quick Heal Technologies Limited

Quick Heal Technologies Limited Q2 FY27 earnings call summary

NSE: QUICKHEAL · BSE: 539678

Earnings call of 28 Oct 2026, summarised by AI from the filing.

Consumer revenue fell 40% YoY to ₹36 cr as credit controls were tightened.

Key takeaways

  1. Consumer decline Consumer revenue fell 40% YoY to ₹36 cr as credit controls were tightened.
  2. Enterprise wins Strategic wins across defence, BFSI and a large IT services company through new-generation products.
  3. Microsoft risk Microsoft's default free antivirus and removal of expired versions is the biggest challenge for antivirus vendors.

Original filing on BSE

Quick Heal Technologies Limited Q2 FY27 results

As filed: Revenue ₹64.9 cr (−23% year on year), EBITDA ₹2.3 cr (−74% year on year), PAT ₹5.8 cr (−28% year on year), EBITDA margin 3.5% (−717 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹45.0 cr (−21% year on year), EBITDA −₹17.6 cr, PAT −₹5.3 cr, EBITDA margin -39.1% (−1,000 bps). Score 28 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 8% from last quarter. Share price after the results: −12.7% in 29 days (Nifty 500: +0.7%).
  • Q4 FY26: Revenue ₹48.7 cr (−25% year on year), EBITDA −₹29.3 cr, PAT −₹19.9 cr, EBITDA margin -60.2% (−1,000 bps). Score 15 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 32% from last quarter. Share price after the results: −16.0% in 29 days (Nifty 500: +2.4%).
  • Q3 FY26: Revenue ₹71.5 cr (+1% year on year), EBITDA ₹0.5 cr, PAT ₹6.6 cr, EBITDA margin 0.6% (+626 bps). Score 37 of 100, Below trend. Revenue growth was below the company's own trend. EBITDA margin rose 626 bps year on year. Other income 156% of PBT. Tax rate -15%. Revenue fell 15% from last quarter. Share price after the results: −11.9% in 29 days (Nifty 500: +0.1%).
  • Q2 FY26: Revenue ₹84.0 cr (+15% year on year), EBITDA ₹9.0 cr (+200% year on year), PAT ₹8.0 cr (+100% year on year), EBITDA margin 10.7% (+660 bps). Score 72 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 660 bps year on year. Other income 40% of PBT. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: −6.9% in 30 days (Nifty 500: +2.0%).
  • Q1 FY26: Revenue ₹57.0 cr (−19% year on year), EBITDA −₹10.0 cr (−300% year on year), PAT −₹6.0 cr (−250% year on year), EBITDA margin -17.5% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 12% from last quarter. Share price after the results: −0.2% in 29 days (Nifty 500: +0.6%).
  • Q4 FY25: Revenue ₹65.0 cr (−19% year on year), EBITDA −₹9.0 cr (−190% year on year), PAT −₹3.0 cr (−121% year on year), EBITDA margin -13.9% (−1,000 bps). Score 20 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 1000 bps year on year. Revenue fell 8% from last quarter. Share price after the results: +39.0% in 30 days (Nifty 500: +4.5%).
  • Q3 FY25: Revenue ₹71.0 cr (−13% year on year), EBITDA −₹4.0 cr (−133% year on year), PAT ₹0.0 cr (−100% year on year), EBITDA margin -5.6% (−1,000 bps). Score 18 of 100, Below trend. Revenue growth was well below the company's own trend. EBITDA margin fell 1000 bps year on year. Profit fell 100% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Quick Heal Technologies Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.